Evidence map›Paper›PMID 28630763›Full record

ArticleEFORT open reviews2017

Malignant tumours of the foot and ankle.

E Mascard, N Gaspar, L Brugières, C Glorion, S Pannier, A Gomez-Brouchet

Open access · goldAbstract read
In one paragraph

Article in EFORT open reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Predictors of malignancy in surgically removed foot and ankle masses: a retrospective multi-center study.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Malignant Bone and Soft Tissue Lesions of the Foot.Journal of clinical medicine · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Lesions of the heel fat pad.The British journal of radiology · 2021
    Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

E MascardNecker University Hospital, 75015 Paris, France.
N GasparDepartment of Pediatrics, Institute Gustave Roussy, 94805 Villejuif, France.
L BrugièresDepartment of Pediatrics, Institute Gustave Roussy, 94805 Villejuif, France.
C GlorionOrthopedic Surgery Department, Necker University Hospital, 149 rue de Sèvres, 75015 Paris, France.
S PannierOrthopedic Surgery Department, Necker University Hospital, 149 rue de Sèvres, 75015 Paris, France.
A Gomez-BrouchetLaboratoire d'anatomie et cytologie pathologiques, Institut Universitaire du Cancer de Toulouse- Oncopole, 1 avenue Irène Joliot-Curie. 31059 Toulouse Cedex 9, France.
Hôpital Necker-Enfants Malades · FRInstitut Gustave Roussy · FRInstitut universitaire du cancer de Toulouse Oncopole · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most of tumours of the foot are tumour-like (synovial cyst, foreign body reactions and epidermal inclusion cyst) or benign conditions (tenosynovial giant cells tumours, planta fibromatosis). Malignant tumours of the soft-tissue and skeleton are very rare in the foot and their diagnosis is often delayed with referral to specialised teams after initial inappropriate procedures or unplanned excisions. The adverse effect of these misdiagnosed tumours is the increasing rate of amputation or local recurrences in the involved patients. In every lump, imaging should be discussed before any local treatment. Every lesion which is not an obvious synovial cyst or plantar fibromatosis should have a biopsy performed.After the age of 40 years, chondrosarcoma is the most usual malignant tumour of the foot. In young patients bone tumours such as osteosarcoma or Ewing's sarcoma, are very unusually located in the foot. Synovial sarcoma is the most frequent histological diagnosis in soft tissues. Epithelioid sarcoma or clear cell sarcoma, involve more frequently the foot and ankle than other sites. The classic local treatment of malignant conditions of the foot and ankle was below-knee amputation at different levels. Nowadays, with the development of adjuvant therapies, some patients may benefit from conservative surgery or partial amputation after multidisciplinary team discussions.The prognosis of foot malignancy is not different from that at other locations, except perhaps in chondrosarcoma, which seems to be less aggressive in the foot. The anatomy of the foot is very complex with many bony and soft tissue structures in a relatively small space making large resections and conservative treatments difficult to achieve. Cite this article:

Indexed as

biopsydiagnosisfoot and ankleimagingmalignant tumourstreatment modalities

Identifiers

PMID28630763
PMCPMC5467685
OpenAlexW2613990607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.